Position in OGN
as of Mar 31, 2026
· filed May 22, 2026
Position Value
$63,889
New position
Shares Held
10,666
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WNY Asset Management, LLC holds $12,807,497 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,610 | $6,728,802 | |
| 2 | JNJ |
Johnson & Johnson
|
6,393 | $1,623,630 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,678 | $1,372,123 | |
| 4 | ABBV |
AbbVie Inc.
|
4,347 | $1,093,879 | |
| 5 | PFE |
Pfizer Inc
|
33,220 | $799,937 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,655 | $729,181 | |
| 7 | NVO |
Novo Nordisk A S
|
5,198 | $249,192 | |
| 8 | AMGN |
Amgen Inc
|
582 | $210,753 |
All Filings in OGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,889 | 10,666 | Shares | Sole | 2026-05-22 | |
| No filing history on record for this holder in this stock. | ||||||